| 中文名称: | Tivozanib (AV-951) |
| 中文别名: | N-[2-氯-4-[(6,7-二甲氧基-4-喹啉基)氧基]苯基]-N'-(5-甲基-3-异恶唑基)脲;AV-951(Tivozanib)替沃扎尼;N-[2-氯-4-[(6,7-二甲氧基-4-喹啉基)氧基]苯基]-N''-(5-甲基-3-异;N-[2-氯-4-[(6,7-二甲氧基-4-喹啉基)氧基]苯基]-N''-(5-甲基-3-异恶唑基)脲;N-[2-氯-4-[(6,7-二甲氧基-4-喹啉基)氧基]苯基]-N-(5-甲基-3-异恶唑基)脲;Tivozanib (AV-951) 抑制剂;Tivozanib标准品;替沃扎尼;N-[2-氯-4-[(6,7-二甲氧基-4-喹啉基)氧基]苯基]-N`-(5-甲基-3-异恶唑基)脲 |
| smiles: | ClC1C([H])=C(C([H])=C([H])C=1N([H])C(N([H])C1C([H])=C(C([H])([H])[H])ON=1)=O)OC1C([H])=C([H])N=C2C([H])=C(C(=C([H])C2=1)OC([H])([H])[H])OC([H])([H])[H] |
| 英文名称: | Tivozanib (AV-951) |
| 英文别名: | N-[2-Chloro-4-[(6,7-dimethoxy-4-quinolyl)oxy]phenyl]-N'-(5-methyl-3-isoxazolyl)urea;Tivozanib (AV-951);1-(2-Chloro-4-((6,7-dimethoxyquinolin-4-yl)-oxy)phenyl)-3-(5-methylisoxazol-3-yl)urea;1-(2-Chloro-4-((6,7-dimethoxyquinolin-4-yl)oxy)phenyl)-3-(5-methylisoxazol-3-yl)urea;1-[2-chloro-4-(6,7-dimethoxyquinolin-4-yl)oxyphenyl]-3-(5-methyl-1,2-oxazol-3-yl)urea;Av951;AV-951;AV951 Tivozanib;Tivozanib;Tivozanib AV-951;Tivozanib(AV-951,ASP4130,KRN-951);AV951,AV-951;KRN-951;Tivozanib,AV951,AV-951;AV 951;KRN951;KRN 951;1-(2-CHLORO-4-(6,7-DIMETHOXYQUINOLIN-4-YLOXY)PHENYL)-3-(5-METHYLISOXAZOL-3-YL)UREA;172030934T;fotivda;Vascular Endothelial Growth Factor Receptor Tyrosine Kinase Inhibitor IV;N-(2-C |
| CAS号: | 475108-18-0 |
| 分子式: | C22H19CLN4O5 |
| 分子量: | 454.86 |
| 密度: | |
| 熔点: | |
| 沸点: | |
| 闪点: | |
| 水溶性: | |
| 蒸气压: |
Tivozanib (AV-951)
英文名:
Tivozanib (AV-951)
别名:N-[2-氯-4-[(6,7-二甲氧基-4-喹啉基)氧基]苯基]-N'-(5-甲基-3-异恶唑基)脲;AV-951(Tivozanib)替沃扎尼;N-[2-氯-4-[(6,7-二甲氧基-4-喹啉基)氧基]苯基]-N''-(5-甲基-3-异;N-[2-氯-4-[(6,7-二甲氧基-4-喹啉基)氧基]苯基]-N''-(5-甲基-3-异恶唑基)脲;N-[2-氯-4-[(6,7-二甲氧基-4-喹啉基)氧基]苯基]-N-(5-甲基-3-异恶唑基)脲;Tivozanib (AV-951) 抑制剂;Tivozanib标准品;替沃扎尼;N-[2-氯-4-[(6,7-二甲氧基-4-喹啉基)氧基]苯基]-N`-(5-甲基-3-异恶唑基)脲
商品编号:R026072-50mg
规格:50mg
纯度:99%
CAS号: 475108-18-0
分子式:C22H19CLN4O5
分子量:454.86
| 价格 |
¥ 9460.00
(请 登录 会员查看折扣价)
|
| 货期 | 5~7个工作日 |
数量
搜索质检报告(COA)
搜索MSDS
相关产品


















